Sickle cell disease is a devastating, inherited blood disorder that affects an estimated eight million people worldwide and ...
At the Cleveland Clinic, doctors are using a one-time gene-editing therapy that alters a patient’s own blood-forming stem cells to correct the genetic mutation responsible for the disease. Physicians ...
Caden Major was born with sickle cell disease – an inherited blood disorder affecting red blood cells. Now at 19 years old, ...
Major is one of the first pediatric patients in Florida to receive gene therapy for sickle cell disease since the FDA ...
Both new FDA-approved medicines offer a potential cure, but they will come with a hefty price tag and it will be years before their long-term effects are clear. Sickle cell disease, a painful ...
Key Highlights Motixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease enabling accelerated access to gene therapies 90% (9 of 10) of ...
He's the first in New York to receive the novel treatment and one of the first in the world. Share on Facebook (opens in a new window) Share on X (opens in a new window) Share on Reddit (opens in a ...
PRESS RELEASEAB SCIENCE PATENT FOR MASITINIB IN THE TREATMENT OF SICKLE CELL DISEASE FORMALLY GRANTED IN THE UNITED STATES WITH A PROTECTION ...
Sickle cell disease (SCD) is an inherited disorder that affects over 100,000 people in the United States, according to the Sickle Cell Disease Association of America, of that number, the Centers for ...
Motixafortide alone and in combination with natalizumab can support the collection of the large number of stem cells required by gene therapies for sickle cell disease within a single apheresis cycle ...
Uganda is among the countries with the highest burden of the disease, with an estimated 33,000 babies born each year carrying the sickle cell trait or disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback